Global Synthetic Biology Industry

NEW YORK, Jan. 9, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Synthetic Biology Industry
http://www.reportlinker.com/p01375238/Global-Synthetic-Biology-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genetically_Modified_Organism,_GMO

This report analyzes the worldwide markets for Synthetic Biology in US$ Thousands by the following Application Areas:
Energy & Chemicals,
Biotechnology & Pharmaceuticals,
and Others.

The report provides separate comprehensive analytics for the
US,
Canada,
Japan,
Europe,
Asia-Pacific,
and Rest of World.

Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

The report profiles 38 companies including many key and niche players such as -
Amyris Biotechnologies, Inc.
ATG Biosynthetics GmbH
BP Plc
Chromatin Inc.
GenScript USA, Inc.

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability And Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions And Scope Of Study I-3

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW II-1
A Quick Primer II-1
Synthetic Biology: Prediction Becoming Reality II-1
Current & Future Analysis II-2
Growth Drivers II-3
Major Concerns II-3
Future Outlook II-4
Synthetic Biology - An Emerging Discipline II-4
Contribution of Synthetic Biology to Biotech II-5
Craig Venter's Synthetic Life: Momentous Achievement in
Synthetic Biology Field II-5
Gibson Assembly®: Building Toolset for Synthetic Biology II-5
Gen9's BioFab: Major Breakthrough in Synthetic Biology II-6
Key Developments in the Synthetic Biology Field II-6
Synthetic Biology Products with Commercial Potential in the
Future II-8

2. MARKET TRENDS AND ISSUES II-10
Is Synthetic Biology a Bane or Boon? II-10
Synthetic Biology Exhibits Plateau in Awareness II-10
Synthetic Biology Research Gathers Momentum II-10
US and Europe - Propelling Research in the Field of Synthetic
Biology II-11
Table 1: Number of Entities Focused on Synthetic Biology
Research Globally: 2009 & 2013 (includes corresponding
Graph/Chart) II-11

Table 2: Synthetic Biology and their Potential Areas of
Applications Being Researched by Biological Systems
Manufacturers/Designers (includes corresponding Graph/Chart) II-12

Table 3: Number of Biological Systems
Manufacturers/Designers Focused on Specialty/ Fine Chemical
Applications (includes corresponding Graph/Chart) II-13
Synthetic Biology Mired by Challenges in Developing Countries II-14
Systems Biology Leading to Advancements in Synthetic Biology II-14
Food and Other Basic Needs' Scarcity to Fuel Synthetic Biology
Market II-14
Food, Water, and Energy Statistics II-15
Do-It-Yourself Biology (DIYBio): A Growing Phenomenon II-15
Synthetic Biology Gaining Prominence in Biomedical Applications II-15
Research Efforts in Full Swing to Treat Life-Threatening
Diseases using Synthetic Biology II-16
Synthetic Biology Therapeutics to Address Antibiotic-
Resistance Crisis II-17
Pipeline Perspective of Synthetic Biology Therapeutics (
Synthetic Biologics and Intrexon Collaboration) II-18
Synthetic Biology for Wildlife Conservation Laden with Risks II-18
Synthetic Biology Gains Significance in Production of Biofuels II-18
Synthetic Biology for Energy Supply: Potential Threat to
Biodiversity II-19
Lack of Regulatory Framework: A Major Cause of Concern II-19

3. PRODUCT OVERVIEW II-21
Introduction II-21
Historical Background II-21
Synthetic Biology Vis-à-vis Genetic Engineering - A Comparison II-21
Scope of Synthetic Biology in Various Fields II-22
Engineering II-22
Chemistry II-22
Major Enabling Technologies II-22
Sequencing II-22
Fabrication II-23
Modeling II-23
Measurement II-23
Market Potential II-23
Pharmaceutical II-23
Industrial II-23
Agriculture II-23
Life Sciences Research II-23
Renewable Energy II-23
Potential Uses II-23

Biomedicine II-24
Intricate Molecular Devices Utilized for Tissue
Regeneration/Repair II-24
Smart Drugs II-24
Biological Delivery Systems II-24
Vectors for Therapy II-24
Personalized Medicine II-24
Cells with Novel Properties for Betterment of Human Health II-25
In Vivo Synthesis of Small-Molecule Pharmaceuticals II-25
Intricate Natural Products II-25
Expansion of Chemistry of Life II-25
Expanding Genetic Alphabet II-25
Nucleic Acids II-25
Proteins II-26
New Imaging and Targeting Methods II-26
Chemical Industry Sustainability II-26
Eco-friendly Production of Chemicals II-26
Energy and Environment II-26
Bioremediation II-26
Energy Production II-26
Biomaterials and Smart Materials Production II-27
Synthesis II-27
Organization II-27
Socio-Economic Concerns and Risks of Synthetic Biology II-27
Production of Bio-Weapons II-27
Accidental Release II-27
Return on Investment II-27
Dissonance with Other Disciplines II-28
Continuous Evolution II-28
Curtailed Understanding II-28
Unpredictable Ecosystem Effects II-28
Unexpected Transfer of Genes II-28
Aggravating Problems II-28
Industry Associations II-29
Synthetic Biology Industry Association (SynBIA) II-29
Industry Association of Synthetic Biology (IASB) II-29

4. KEY RESEARCH FINDINGS ON SYNTHETIC BIOLOGY II-30
Synthetic Biology In Repelling Viruses II-30
Synthetic Biology in Engineered Food II-30
Synthetic Biology to Address Issues Related to Algal Blooms II-30
Synthetic Biology Holds Potential for Testing Water Purity II-30
Mars - A Home Away from Home Courtesy Synthetic Biology II-30
Predictable Biological Systems - No More a Myth II-30
Researchers at JCVI Make Novel Advances in Synthetic Genomics II-31
Synthetic Biology Tools Can Detect Listeria Contamination in
Food Products II-31
Synthetic Biology Accelerates Flu Vaccine Production II-32
Bioengineers at Duke University Develops Novel System for
Reproducing Natural Complex Gene Regulation II-32
TALE: A Viable Technology for Synthetic Protein Development II-33
Can Synthetic Biology Fuel Cars or Household Power Supplies
Using Naturally-Existing Fatty Acids? II-33
Researchers Engineered Synthetic Compound to Defend Iron
Deficiency II-33
Cellular Circuit Designing Made Possible through Biological Genes II-33
Meshing Inputs/Outputs Offer Layered Circuits II-34
Cambrian Genomics Pioneers DNA Laser Printer II-34
Researchers Develop Novel Technique that Speeds the Process
for Developing New Biological Parts II-34
Researchers Develop Novel Biological Device that Mimics
Transistor-Like Properties II-35

5. PRODUCT INNOVATIONS/INTRODUCTIONS II-36
Life Technologies Unveils Vector NTI® Express Designer
Bioinformatics Software Platform II-36
Gen9 Introduces GeneBytesTM DNA Constructs II-36
New England Biolabs and Synthetic Genomics Launches Gibson
Assembly Cloning Kit and NEBuilderTM Primer Design Tool II-37
GenScript Introduces Gene-Brick™ Gene Synthesis Service II-37
DNA2.0 Successfully Integrates SBOL into Gene Designer
Biological Design Tool II-38
454 Life Sciences to Introduce GS Junior System and Improve
Genome Sequencer FLX System II-38
DNA2.0 Launches pJexpress II-39
febit Introduces miRBase 14.0-based miRNA Biochip II-39
Codexis Launches Codex™ MicroCyp Plate II-39
GeneWorks Expands Genome Analysis Services II-39

6. RECENT INDUSTRY ACTIVITY II-40
Sanofi Commences Large-Scale Production of Semi-Synthetic
Artemisinin II-40
EVOLVA and IFF Enter into Pre-Manufacturing Phase for Natural
Vanillin II-40
Synthetic Genomics Enters into Research Agreement with ExxonMobil II-40
Amyris Signs Long Term Agreement with International Flavors &
Fragrances II-41
SGI-DNA and IDT Announce Expanded Collaboration II-41
College of Engineering Establishes BU Center of Synthetic Biology II-42
Gen9 Enters into Partnership with Agilent Technologies II-42
AquaBounty Technologies Enters into Exclusive Channel
Collaboration with Intrexon II-43
Synthetic Biologics Collaborates with Intrexon for Infectious
Disease Therapies II-43
DuPont Collaborates with OligoCo II-44
DNA2.0 Collaborates with Newcastle University II-44
Amyris Secures Contract from the US DARPA II-45
Pfenex Collaborates with DNA2.0 II-45
Synthetic Genomics Inks Agreement with New England Biolabs II-45

Amyris Commences Production of Biofene in Brazil II-46
Amyris Takes Over Draths II-46
Intrexon Collaborates with Adeona Pharmaceuticals for PAH Therapy II-46
febit biomed Changes Name to Comprehensive Biomarker Center II-47
Life Technologies Inks Exclusive License Agreement with the
Inventors of TAL Effector Technology II-47
Amyris Inks Agreement with Givaudan II-48
LS9 Expands Strategic Partnership with P&G II-48
Amyris Commissions Industry-Scale Production of Biofene® II-48
Intrexon Establishes Cell Engineering Unit in California II-49
Halozyme Enters into Exclusive Worldwide Licensing Agreement
with Intrexon II-49
Evozym Biologics Forms Strategic Business Alliance and
Collaboration with GenScript II-50
Intrexon Takes Over Neugenesis II-50
ZIOPHARM Oncology Enters into Partnership with Intrexon II-51
Amyris Brasil Inks Agreements with Acucar Guarani, Bunge and
Cosan Group II-51
Amyris Brasil Inaugurates Demonstration Facility II-52

Amyris Biotechnologies to Acquire Stake in Boa Vista Mill from
São Martinho Group II-52
Synthetic Genomics Inks Agreement with ExxonMobil Research and
Engineering Company II-52
Verdezyne Inks Agreement with Novozymes II-53
Verdezyne Collaborates with Genencor II-53
OneWorld Health, Sanofi-aventis and Amyris Biotechnologies
Enter into Partnership II-53
Amyris Biotechnologies Enters into Partnership with Crystalsev II-54
GENEART Extends Partnership with QIAGEN II-54
LC Sciences and DNAVision Enter into Strategic Marketing Alliance II-55

7. FOCUS ON SELECT PLAYERS II-56
Players Focused on Synthetic Biology Applications Amyris
Biotechnologies, Inc. (US) II-56
BP PLC. (UK) II-56
Chromatin Inc. (US) II-57
E. I. du Pont de Nemours and Company (US) II-57
Evolva SA (Switzerland) II-58
Gevo, Inc. (US) II-58

Joule Unlimited, Inc. (US) II-59
LS9, Inc. (US) II-59
Metabolix (US) II-59
MorphoSys AG (Germany) II-59
Sapphire Energy, Inc. (US) II-60
Solazyme, Inc. (US) II-60
Synthetic Biologics, Inc. (US) II-60
Synthetic Genomics, Inc. (US) II-60
Players Focused on Gene Synthesis and Tools II-61
454 Life Sciences (US) II-61
Agilent Technologies Inc. (US) II-61
ATG Biosynthetics GmbH (Germany) II-62
DNA2.0 (US) II-62
Epoch Life Science, Inc. (US II-63
Gen9 Inc (US) II-63
GenScript USA, Inc. (US) II-64
Gingko Bioworks Inc (US) II-64
Intrexon Corporation (US) II-65
LC Sciences LLC (US) II-65
Life Technologies Corp. (US) II-65
OPXBIO Inc. II-66
OriGene Technologies, Inc. II-66
Sangamo BioSciences, Inc. (US) II-67
Verdezyne, Inc. II-67

8. GLOBAL MARKET PERSPECTIVE II-68
Table 4: World Recent Past, Current & Future Analysis for
Synthetic Biology by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific, and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2010 through 2018 (includes corresponding Graph/Chart) II-68

Table 5: World Historic Review for Synthetic Biology by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific,
and Rest of World Markets Independently Analyzed with Annual
Sales Figures in US$ Thousand for Years 2004 through 2009
(includes corresponding Graph/Chart) II-69

Table 6: World 15-Year Perspective for Synthetic Biology by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific, and Rest of World
Markets for Years 2004, 2013 & 2018 (includes corresponding
Graph/Chart) II-70

Table 7: World Recent Past, Current & Future Analysis for
Synthetic Biology by End-Use Sector - Energy & Chemicals,
Biotechnology & Pharmaceuticals, and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2010 through 2018 (includes corresponding
Graph/Chart) II-71

Table 8: World Historic Review for Synthetic Biology by
End-Use Sector - Energy & Chemicals, Biotechnology &
Pharmaceuticals, and Others Markets Independently Analyzed
with Annual Sales Figures in US$ Thousand for Years 2004
through 2009 (includes corresponding Graph/Chart) II-72

Table 9: World 15-Year Perspective for Synthetic Biology by
End-Use Sector - Percentage Breakdown of Dollar Sales for
Energy & Chemicals, Biotechnology & Pharmaceuticals, and
Others Markets for Years 2004, 2013 & 2018 (includes
corresponding Graph/Chart) II-73

III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Current & Future Analysis III-1
Research in the US III-1
Table 10: Number of Entities Focused on Synthetic Biology
Research in the US (2009 & 2013) (includes corresponding
Graph/Chart) III-1
International Genetically Engineered Machine (IGEM) - A
Platform for Innovations III-2
Product Launches III-2
Strategic Corporate Developments III-4
Key Players III-15
B.Market Analytics III-25
Table 11: US Recent Past, Current & Future Analysis for
Synthetic Biology Market - Analyzed with Annual Sales
Figures in US$ Thousand for Years 2010 through 2018
(includes corresponding Graph/Chart) III-25

Table 12: US Historic Review for Synthetic Biology Market -
Analyzed with Annual Sales Figures in US$ Thousand for Years
2004 through 2009 (includes corresponding Graph/Chart) III-25

2. CANADA III-26
A.Market Analysis III-26
Current & Future Analysis III-26
B.Market Analytics III-26
Table 13: Canadian Recent Past, Current & Future Analysis
for Synthetic Biology Market - Analyzed with Annual Sales
Figures in US$ Thousand for Years 2010 through 2018
(includes corresponding Graph/Chart) III-26

Table 14: Canadian Historic Review for Synthetic Biology
Market - Analyzed with Annual Sales Figures in US$ Thousand
for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-27

3. JAPAN III-28
A.Market Analysis III-28
Current & Future Analysis III-28
B.Market Analytics III-28
Table 15: Japanese Recent Past, Current & Future Analysis
for Synthetic Biology Market - Analyzed with Annual Sales
Figures in US$ Thousand for Years 2010 through 2018
(includes corresponding Graph/Chart) III-28

Table 16: Japanese Historic Review for Synthetic Biology
Market - Analyzed with Annual Sales Figures in US$ Thousand
for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-29

4. EUROPE III-30
A.Market Analysis III-30
Current & Future Analysis III-30
Research in Europe III-30
Table 17: Number of Entities Focused on Synthetic Biology
Research in Europe (2009 & 2013) (includes corresponding
Graph/Chart) III-31
B.Market Analytics III-32
Table 18: European Recent Past, Current & Future Analysis
for Synthetic Biology by Geographic Region - France,
Germany, Italy, UK, Spain and Rest of Europe Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-32

Table 19: European Historic Review for Synthetic Biology by
Geographic Region - France, Germany, Italy, UK, Spain and
Rest of Europe Markets Independently Analyzed with Annual
Sales Figures in US$ Thousand for Years 2004 through 2009
(includes corresponding Graph/Chart) III-33

Table 20: European 15-Year Perspective for Synthetic Biology
by Geographic Region - Percentage Breakdown of Value Sales
for France, Germany, Italy, UK, Spain and Rest of Europe
Markets for Years 2004, 2013 & 2018 (includes corresponding
Graph/Chart) III-34

4a. FRANCE III-35
A.Market Analysis III-35
Current & Future Analysis III-35
Strategic Corporate Development III-35
B.Market Analytics III-36
Table 21: French Recent Past, Current & Future Analysis for
Synthetic Biology Market - Analyzed with Annual Sales
Figures in US$ Thousand for Years 2010 through 2018
(includes corresponding Graph/Chart) III-36

Table 22: French Historic Review for Synthetic Biology
Market - Analyzed with Annual Sales Figures in US$ Thousand
for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-36

4b. GERMANY III-37
A.Market Analysis III-37
Current & Future Analysis III-37
Strategic Corporate Development III-37
Key Players III-37
B.Market Analytics III-38
Table 23: German Recent Past, Current & Future Analysis for
Synthetic Biology Market - Analyzed with Annual Sales
Figures in US$ Thousand for Years 2010 through 2018
(includes corresponding Graph/Chart) III-38

Table 24: German Historic Review for Synthetic Biology
Market - Analyzed with Annual Sales Figures in US$ Thousand
for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-39

4c. ITALY III-40
A.Market Analysis III-40
Current & Future Analysis III-40
B.Market Analytics III-40
Table 25: Italian Recent Past, Current & Future Analysis for
Synthetic Biology Market - Analyzed with Annual Sales
Figures in US$ Thousand for Years 2010 through 2018
(includes corresponding Graph/Chart) III-40

Table 26: Italian Historic Review for Synthetic Biology
Market - Analyzed with Annual Sales Figures in US$ Thousand
for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-41

4d. THE UNITED KINGDOM III-42
A.Market Analysis III-42
Current & Future Analysis III-42
Market Overview III-42
UK Government Awards Over £6 Million Grant for Synthetic
Biology III-42
UK Government Funding for Synthetic Biology: 2013 III-43
SynbiCITE Centre to Spearhead UK Research in Synthetic Biology III-43
BP PLC. - A Key Player III-43
B.Market Analytics III-44
Table 27: UK Recent Past, Current & Future Analysis for
Synthetic Biology Market - Analyzed with Annual Sales
Figures in US$ Thousand for Years 2010 through 2018
(includes corresponding Graph/Chart) III-44

Table 28: UK Historic Review for Synthetic Biology Market -
Analyzed with Annual Sales Figures in US$ Thousand for Years
2004 through 2009 (includes corresponding Graph/Chart) III-45

4e. SPAIN III-46
A.Market Analysis III-46
Current & Future Analysis III-46
B.Market Analytics III-46
Table 29: Spanish Recent Past, Current & Future Analysis for
Synthetic Biology Market - Analyzed with Annual Sales
Figures in US$ Thousand for Years 2010 through 2018
(includes corresponding Graph/Chart) III-46

Table 30: Spanish Historic Review for Synthetic Biology
Market - Analyzed with Annual Sales Figures in US$ Thousand
for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-47

4f. REST OF EUROPE III-48
A.Market Analysis III-48
Current & Future Analysis III-48
Strategic Corporate Development III-48
Evolva SA (Switzerland) - A Major Player III-48
B.Market Analytics III-49
Table 31: Rest of Europe Recent Past, Current & Future
Analysis for Synthetic Biology Market - Analyzed with Annual
Sales Figures in US$ Thousand for Years 2010 through 2018
(includes corresponding Graph/Chart) III-49

Table 32: Rest of Europe Historic Review for Synthetic
Biology Market - Analyzed with Annual Sales Figures in US$
Thousand for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-50

5. ASIA-PACIFIC III-51
A.Market Analysis III-51
Current & Future Analysis III-51
Table 33: Number of Entities Focused on Synthetic Biology
Research in Asia and Oceania in 2013 (includes
corresponding Graph/Chart) III-51
B.Market Analytics III-51
Table 34: Asia-Pacific Recent Past, Current & Future
Analysis for Synthetic Biology Market - Analyzed with Annual
Sales Figures in US$ Thousand for Years 2010 through 2018
(includes corresponding Graph/Chart) III-51

Table 35: Asia-Pacific Historic Review for Synthetic Biology
Market - Analyzed with Annual Sales Figures in US$ Thousand
for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-52

6. REST OF WORLD III-53
A.Market Analysis III-53
Current & Future Analysis III-53
Strategic Corporate Development III-53
B.Market Analytics III-53
Table 36: Rest of World Recent Past, Current & Future
Analysis for Synthetic Biology Market - Analyzed with Annual
Sales Figures in US$ Thousand for Years 2010 through 2018
(includes corresponding Graph/Chart) III-53

Table 37: Rest of World Historic Review for Synthetic
Biology Market - Analyzed with Annual Sales Figures in US$
Thousand for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-54

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 38 (including Divisions/Subsidiaries - 39)

The United States (30)
Canada (1)
Europe (6)
- France (1)
- Germany (3)
- The United Kingdom (1)
- Rest of Europe (1)
Asia-Pacific (Excluding Japan) (2)

To order this report: Global Synthetic Biology Industry
http://www.reportlinker.com/p01375238/Global-Synthetic-Biology-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genetically_Modified_Organism,_GMO

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker



RELATED LINKS
http://www.reportlinker.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.